Global Wealth Management Investment Advisory’s Novavax NVAX Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-90	Closed	-$432	–	334
2023 Q4	$432	Hold	90	–	–	﹤0.01%	445
2023 Q3	$652	Hold	90	–	–	﹤0.01%	435
2023 Q2	$669	Buy	+90	New	+$708	﹤0.01%	435
2022 Q3	–	Sell	-90	Closed	-$5K	–	356
2022 Q2	$5K	Hold	90	–	–	﹤0.01%	341
2022 Q1	$7K	Buy	+90	New	+$8.03K	﹤0.01%	345
2021 Q3	–	Sell	-10	Closed	-$2K	–	481
2021 Q2	$2K	Buy	+10	New	+$1.83K	﹤0.01%	397
2021 Q1	–	Sell	-84	Closed	-$9K	–	501
2020 Q4	$9K	Buy	84 +10	+14%	+$1.06K	﹤0.01%	294
2020 Q3	$8K	Sell	74 -26	-26%	-$3.17K	﹤0.01%	292
2020 Q2	$8K	Buy	+100	New	+$3.83K	﹤0.01%	379

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Global Wealth Management Investment Advisory's NVAX Position: Q1 2024 in Review

Global Wealth Management Investment Advisory sold out of Novavax (NVAX) in Q1 2024, closing a stake of 90 shares — an estimated $432 sold.

Global Wealth Management Investment Advisory first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $9K in Q4 2020. 202 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

Global Wealth Management Investment Advisory reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
Global Wealth Management Investment Advisory sold 90 Novavax shares in Q1 2024, an estimated $432.
Global Wealth Management Investment Advisory first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
Global Wealth Management Investment Advisory's Novavax position peaked at $9K in Q4 2020.
202 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.